首页|糖肾地黄汤通过调控lncRNA-ARAP1/miR-25-3p/SGLT2轴延缓糖尿病肾病进展的机制研究

糖肾地黄汤通过调控lncRNA-ARAP1/miR-25-3p/SGLT2轴延缓糖尿病肾病进展的机制研究

扫码查看
目的 探究糖肾地黄汤通过调控lncRNA-ARAP1/miR-25-3p/SGLT2轴延缓糖尿病肾病进展的机制.方法 用小鼠单侧肾切除+腹腔注射链脲佐菌素(Streptozotocin,STZ)诱导糖尿病肾病(Diabetic nephropathy,DN)模型,选择糖尿病肾病小鼠模型组共45只小鼠,雌性CBA/J 30只,雄性DBA/2 15只,另选正常健康小鼠10只作为正常对照组.将造模的糖尿病肾病小鼠分为模型组、糖肾地黄汤高剂量组(TSDHDHD组)、糖肾地黄汤中剂量组(TSDHDMD组)、糖肾地黄汤低剂量组(TSDHDLD组),每组10只.HE染色检测小鼠的病理学变化,应用全自动生化分析仪对所获得小鼠血清空腹血糖(Fasting blood glucose,FBG),甘油三酯(Triglyceride,TG),胆固醇(Cholesterol,TC)水平,RT-PCR 法分析ARAP1、miR-25-3p、SGLT2、Bax/Bcl-2mRNA 的表达,免疫印迹法(Westernblot,Wb)分析 ARAP1、miR-25-3p、SGLT2、Bax/Bcl-2的蛋白表达.采用SPSS 23.0统计软件.结果 对照组中细胞排列致密整齐、完整,存在少量脂肪细胞(P>0.05);与对照组比较,模型组细胞结构较为散乱,且由稀疏变细,近端脂肪细胞数目增多,差异存在统计学意义(P<0.05);相比模型组,各剂量组糖肾地黄汤脂肪细胞数目下降,比较存在统计学差异(P<0.05).与对照组相比,模型组、不同剂量糖肾地黄汤组油红O染色镜下IOD表达明显升高(P<0.05);与模型组相比,不同剂量糖肾地黄汤组油红O染色镜下IOD表达降低(P<0.05);与中、低剂量糖肾地黄汤组相比,高剂量糖肾地黄汤组油红O染色镜下IOD表达降低(P<0.05).治疗前与对照组相比,模型组、不同剂量糖肾地黄汤组模型组FBG水平升高(P<0.05),模型组与不同剂量糖肾地黄汤组相比无统计学差异(P>0.05);与治疗前相比,治疗12周后不同剂量糖肾地黄汤组模型组FBG水平均降低(P<0.05).与对照组相比,模型组、不同剂量糖肾地黄汤组TG、TC水平明显升高(P<0.05);与模型组相比,不同剂量糖肾地黄汤组TG、TC水平降低(P<0.05);与中、低剂量糖肾地黄汤组相比,高剂量糖肾地黄汤组TG、TC水平降低(P<0.05).与对照组相比,模型组、不同剂量糖肾地黄汤组ARAP1、miR-25-3p、SGLT2mRNA水平明显升高,Bax/Bcl-2mRNA水平明显降低(P<0.05);与模型组相比,不同剂量糖肾地黄汤组ARAP1、miR-25-3p、SGLT2mRNA水平降低,Bax/Bcl-2mRNA水平明显升高(P<0.05);与中、低剂量糖肾地黄汤组相比,高剂量糖肾地黄汤组ARAP1、miR-25-3p、SGLT2mRNA水平降低,Bax/Bcl-2mRNA水平明显升高(P<0.05).与对照组相比,模型组、不同剂量糖肾地黄汤组ARAP1、miR-25-3p、SGLT2蛋白表达明显升高,Bax/Bcl-2蛋白表达明显降低(P<0.05);与模型组相比,不同剂量糖肾地黄汤组ARAP1、miR-25-3p、SGLT2水平降低,Bax/Bcl-2蛋白表达明显升高(P<0.05);与中、低剂量糖肾地黄汤组相比,高剂量糖肾地黄汤组ARAP1、miR-25-3p、SGLT2蛋白表达降低,Bax/Bcl-2蛋白表达明显升高(P<0.05).结论 糖肾地黄汤可能通过调节lncRNA-ARAP1/miR-25-3p/SGLT2轴,从而达到延缓糖尿病肾病进展的目的.
Mechanism of Tangshen Dihuang Decoction(糖肾地黄汤)Delaying Diabetic Nephropathy Progression by Regulating lncRNA-ARAP1/miR-25-3p/SGLT2 Axis
Objective To explore the mechanism of Tangshen Dihuang Decoction(糖肾地黄汤)delaying the progression of di-abetic nephropathy by regulating lncRNA-ARAP1/miR-25-3p/SGLT2 axis.Methods Diabetic nephropathy(DN)model was induced by unilateral nephrectomy plus intrabitoneal injection of streptozotocin(STZ).Forty-five mice in the DN model group were selected,including 30 female CBA/J mice and 15 male DBA/2 mice,and 10 healthy mice were selected as the normal con-trol group.DN mice were divided into model group,Tangshen Dihuang Decoction high-dose group(TSDHDHD group),Tangsh-en Dihuang Decoction medium-dose group(TSDHDMD group)and Tangshen Dihuang Decoction low-dose group(TSDHDLD group),with 10 mice in each group.The pathological changes of mice were detected by HE staining.The levels of serum fasting blood glucose(FBG),triglyceride(TG)and cholesterol(TC)of mice were measured by automatic biochemical analyzer.The mRNA expressions of ARAP1,miR-25-3p,SGLT2 and Bax/Bcl-2 were analyzed by RT-PCR.The protein expressions of ARAP1,miR-25-3p,SGLT2 and Bax/Bcl-2 were analyzed by Western blotting.SPSS 23.0 statistical software was used.Re-sults In the control group,the cells were arranged neatly and completely,and there were a few adipocytes(P>0.05).Compared with that in the control group,the cell structure in the model group was scattered,thinning from sparse,and the number of proxi-mal adipocytes increased,with statistical difference(P<0.05).Compared with that in the model group,the number of adipocytes in Tangshen Dihuang Decoction each dose group decreased with statistical difference(P<0.05).Compared with that in the con-trol group,IOD expression in the model group and Tangshen Dihuang Decoction each dose group was significantly increased by oil red O staining(P<0.05).Compared with that in the model group,the IOD expression in Tangshen Dihuang Decoction each dose group was decreased under oil red O staining(P<0.05).IOD expression in the TSDHDHD group was decreased by oil red O staining compared with that in the TSDHDMD group and TSDHDLD group(P<0.05).Compared with that in the control group before treatment,the FBG levels in the model group and Tangshen Dihuang Decoction each dose group were increased(P<0.05),but there was no statistical difference among model group and Tangshen Dihuang Decoction each dose group(P>0.05).Compared with those before treatment,after 12 weeks of treatment,the FBG levels of the model group and Tangshen Dihuang De-coction each dose group were decreased(P<0.05).Compared with those of the control group,the levels of TG and TC in the model group and Tangshen Dihuang Decoction each dose group were significantly increased(P<0.05).Compared with those of the model group,the levels of TG and TC in the Tangshen Dihuang Decoction each dose group were decreased(P<0.05).The levels of TG and TC in the TSDHDHD group were lower than those in the TSDHDMD group and TSDHDLD group(P<0.05).Compared with those of the control group,the mrna levels of ARAP1,miR-25-3p and SglT2 were significantly increased in the model group and Tangshen Dihuang Decoction each dose group,while the mRNA levels of Bax/Bcl-2 were significantly de-creased(P<0.05).Compared with those of the model group,the mRNA levels of ARAP1,miR-25-3p and SglT2 were de-creased,while the mRNA levels of Bax/Bcl-2 were significantly increased in Tangshen Dihuang Decoction each dose group(P<0.05).Compared with those of the TSDHDMD group and TSDHDLD group,the mRNA levels of ARAP1,miR-25-3p and SglT2 were decreased in the TSDHDHD group,while the mRNA levels of Bax/Bcl-2 were significantly increased(P<0.05).Compared with those of the control group,the protein expressions of ARAP1,miR-25-3p and SGLT2 in the model group and Tangshen Dihuang Decoction each dose group were significantly increased,while the protein expression of Bax/Bcl-2 was signif-icantly decreased(P<0.05).Compared with those of the model group,the levels of ARAP1,miR-25-3p and SGLT2 in Tang-shen Dihuang Decoction each dose group were decreased,while the protein expression of Bax/Bcl-2 was significantly increased(P<0.05).Compared with those of the TSDHDMD group and TSDHDLD group,the protein expressions of ARAP1,miR-25-3p and SGLT2 in the TSDHDHD group were decreased,while the protein expressions of Bax/Bcl-2 were significantly increased(P<0.05).Conclusion Tangshen Dihuang Decoction may delay the progression of DN by regulating the lncRNA-ARAP1/miR-25-3p/SGLT2 axis.

Tangshen Dihuang Decoction(糖肾地黄汤)lncRNA-ARAP1/miR-25-3p/SGLT2 axisdiabetic nephropa-thy

何小泉、章良佑

展开 >

广州中医药大学第一附属医院,广东广州 510405

糖肾地黄汤 lncRNA-ARAP1/miR-25-3p/SGLT2轴 糖尿病肾病

广东省中医药局科研项目

20232064

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(6)
  • 29